Global Cold Medicine Market Research Report 2022

Global Cold Medicine Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drops
1.2.3 Dropping Pill
1.2.4 Capsule
1.2.5 Granules
1.2.6 Tablets
1.2.7 Solution
1.2.8 Syrups
1.2.9 Pills
1.2.10 Injection
1.2.11 Other
1.3 Market by Application
1.3.1 Global Cold Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Baby
1.3.3 Young Children
1.3.4 Preschooler
1.3.5 School-Age Children
1.3.6 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cold Medicine Market Perspective (2017-2028)
2.2 Cold Medicine Growth Trends by Region
2.2.1 Cold Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cold Medicine Historic Market Size by Region (2017-2022)
2.2.3 Cold Medicine Forecasted Market Size by Region (2023-2028)
2.3 Cold Medicine Market Dynamics
2.3.1 Cold Medicine Industry Trends
2.3.2 Cold Medicine Market Drivers
2.3.3 Cold Medicine Market Challenges
2.3.4 Cold Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Medicine Players by Revenue
3.1.1 Global Top Cold Medicine Players by Revenue (2017-2022)
3.1.2 Global Cold Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Cold Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold Medicine Revenue
3.4 Global Cold Medicine Market Concentration Ratio
3.4.1 Global Cold Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Medicine Revenue in 2021
3.5 Cold Medicine Key Players Head office and Area Served
3.6 Key Players Cold Medicine Product Solution and Service
3.7 Date of Enter into Cold Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Medicine Breakdown Data by Type
4.1 Global Cold Medicine Historic Market Size by Type (2017-2022)
4.2 Global Cold Medicine Forecasted Market Size by Type (2023-2028)
5 Cold Medicine Breakdown Data by Application
5.1 Global Cold Medicine Historic Market Size by Application (2017-2022)
5.2 Global Cold Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cold Medicine Market Size (2017-2028)
6.2 North America Cold Medicine Market Size by Country (2017-2022)
6.3 North America Cold Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cold Medicine Market Size (2017-2028)
7.2 Europe Cold Medicine Market Size by Country (2017-2022)
7.3 Europe Cold Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Medicine Market Size (2017-2028)
8.2 Asia-Pacific Cold Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Cold Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cold Medicine Market Size (2017-2028)
9.2 Latin America Cold Medicine Market Size by Country (2017-2022)
9.3 Latin America Cold Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Medicine Market Size (2017-2028)
10.2 Middle East & Africa Cold Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Cold Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Wyeth (Pfizer)
11.1.1 Wyeth (Pfizer) Company Detail
11.1.2 Wyeth (Pfizer) Business Overview
11.1.3 Wyeth (Pfizer) Cold Medicine Introduction
11.1.4 Wyeth (Pfizer) Revenue in Cold Medicine Business (2017-2022)
11.1.5 Wyeth (Pfizer) Recent Development
11.2 Atley Pharmaceuticals
11.2.1 Atley Pharmaceuticals Company Detail
11.2.2 Atley Pharmaceuticals Business Overview
11.2.3 Atley Pharmaceuticals Cold Medicine Introduction
11.2.4 Atley Pharmaceuticals Revenue in Cold Medicine Business (2017-2022)
11.2.5 Atley Pharmaceuticals Recent Development
11.3 Vertical Pharmaceuticals
11.3.1 Vertical Pharmaceuticals Company Detail
11.3.2 Vertical Pharmaceuticals Business Overview
11.3.3 Vertical Pharmaceuticals Cold Medicine Introduction
11.3.4 Vertical Pharmaceuticals Revenue in Cold Medicine Business (2017-2022)
11.3.5 Vertical Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold Medicine Introduction
11.4.4 Novartis Revenue in Cold Medicine Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Cold Medicine Introduction
11.5.4 Merck Revenue in Cold Medicine Business (2017-2022)
11.5.5 Merck Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Cold Medicine Introduction
11.6.4 Sanofi Revenue in Cold Medicine Business (2017-2022)
11.6.5 Sanofi Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cold Medicine Introduction
11.7.4 Johnson & Johnson Revenue in Cold Medicine Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Toray Industries
11.8.1 Toray Industries Company Detail
11.8.2 Toray Industries Business Overview
11.8.3 Toray Industries Cold Medicine Introduction
11.8.4 Toray Industries Revenue in Cold Medicine Business (2017-2022)
11.8.5 Toray Industries Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Cold Medicine Introduction
11.9.4 Bayer Revenue in Cold Medicine Business (2017-2022)
11.9.5 Bayer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Cold Medicine Introduction
11.10.4 Bristol-Myers Squibb Revenue in Cold Medicine Business (2017-2022)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Tongrentang Pharmaceutical
11.11.1 Tongrentang Pharmaceutical Company Detail
11.11.2 Tongrentang Pharmaceutical Business Overview
11.11.3 Tongrentang Pharmaceutical Cold Medicine Introduction
11.11.4 Tongrentang Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.11.5 Tongrentang Pharmaceutical Recent Development
11.12 Jinghua Pharmaceutical Group
11.12.1 Jinghua Pharmaceutical Group Company Detail
11.12.2 Jinghua Pharmaceutical Group Business Overview
11.12.3 Jinghua Pharmaceutical Group Cold Medicine Introduction
11.12.4 Jinghua Pharmaceutical Group Revenue in Cold Medicine Business (2017-2022)
11.12.5 Jinghua Pharmaceutical Group Recent Development
11.13 Jiangxi Heying Pharmaceutical
11.13.1 Jiangxi Heying Pharmaceutical Company Detail
11.13.2 Jiangxi Heying Pharmaceutical Business Overview
11.13.3 Jiangxi Heying Pharmaceutical Cold Medicine Introduction
11.13.4 Jiangxi Heying Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.13.5 Jiangxi Heying Pharmaceutical Recent Development
11.14 Diao Group Chengdu Pharmaceutical
11.14.1 Diao Group Chengdu Pharmaceutical Company Detail
11.14.2 Diao Group Chengdu Pharmaceutical Business Overview
11.14.3 Diao Group Chengdu Pharmaceutical Cold Medicine Introduction
11.14.4 Diao Group Chengdu Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.14.5 Diao Group Chengdu Pharmaceutical Recent Development
11.15 Shanghai Shangyao Xinyi Pharmaceutical
11.15.1 Shanghai Shangyao Xinyi Pharmaceutical Company Detail
11.15.2 Shanghai Shangyao Xinyi Pharmaceutical Business Overview
11.15.3 Shanghai Shangyao Xinyi Pharmaceutical Cold Medicine Introduction
11.15.4 Shanghai Shangyao Xinyi Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.15.5 Shanghai Shangyao Xinyi Pharmaceutical Recent Development
11.16 Harbin Children Pharmaceutical
11.16.1 Harbin Children Pharmaceutical Company Detail
11.16.2 Harbin Children Pharmaceutical Business Overview
11.16.3 Harbin Children Pharmaceutical Cold Medicine Introduction
11.16.4 Harbin Children Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.16.5 Harbin Children Pharmaceutical Recent Development
11.17 Huarun Sanjiu Pharmaceutical
11.17.1 Huarun Sanjiu Pharmaceutical Company Detail
11.17.2 Huarun Sanjiu Pharmaceutical Business Overview
11.17.3 Huarun Sanjiu Pharmaceutical Cold Medicine Introduction
11.17.4 Huarun Sanjiu Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.17.5 Huarun Sanjiu Pharmaceutical Recent Development
11.18 Xinjiang Quanan Pharmaceutical
11.18.1 Xinjiang Quanan Pharmaceutical Company Detail
11.18.2 Xinjiang Quanan Pharmaceutical Business Overview
11.18.3 Xinjiang Quanan Pharmaceutical Cold Medicine Introduction
11.18.4 Xinjiang Quanan Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.18.5 Xinjiang Quanan Pharmaceutical Recent Development
11.19 Jiangsu Huayang Pharmaceutical
11.19.1 Jiangsu Huayang Pharmaceutical Company Detail
11.19.2 Jiangsu Huayang Pharmaceutical Business Overview
11.19.3 Jiangsu Huayang Pharmaceutical Cold Medicine Introduction
11.19.4 Jiangsu Huayang Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.19.5 Jiangsu Huayang Pharmaceutical Recent Development
11.20 Nanjing Chenggong Pharmaceutical
11.20.1 Nanjing Chenggong Pharmaceutical Company Detail
11.20.2 Nanjing Chenggong Pharmaceutical Business Overview
11.20.3 Nanjing Chenggong Pharmaceutical Cold Medicine Introduction
11.20.4 Nanjing Chenggong Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.20.5 Nanjing Chenggong Pharmaceutical Recent Development
11.21 Beijing Jiulong Pharmaceutical
11.21.1 Beijing Jiulong Pharmaceutical Company Detail
11.21.2 Beijing Jiulong Pharmaceutical Business Overview
11.21.3 Beijing Jiulong Pharmaceutical Cold Medicine Introduction
11.21.4 Beijing Jiulong Pharmaceutical Revenue in Cold Medicine Business (2017-2022)
11.21.5 Beijing Jiulong Pharmaceutical Recent Development
11.22 Livzon Pharmaceutical Group
11.22.1 Livzon Pharmaceutical Group Company Detail
11.22.2 Livzon Pharmaceutical Group Business Overview
11.22.3 Livzon Pharmaceutical Group Cold Medicine Introduction
11.22.4 Livzon Pharmaceutical Group Revenue in Cold Medicine Business (2017-2022)
11.22.5 Livzon Pharmaceutical Group Recent Development
11.23 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.23.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
11.23.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.23.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Cold Medicine Introduction
11.23.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Cold Medicine Business (2017-2022)
11.23.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.24 Sinopharm
11.24.1 Sinopharm Company Detail
11.24.2 Sinopharm Business Overview
11.24.3 Sinopharm Cold Medicine Introduction
11.24.4 Sinopharm Revenue in Cold Medicine Business (2017-2022)
11.24.5 Sinopharm Recent Development
11.25 CSPC
11.25.1 CSPC Company Detail
11.25.2 CSPC Business Overview
11.25.3 CSPC Cold Medicine Introduction
11.25.4 CSPC Revenue in Cold Medicine Business (2017-2022)
11.25.5 CSPC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cold Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Drops
Table 3. Key Players of Dropping Pill
Table 4. Key Players of Capsule
Table 5. Key Players of Granules
Table 6. Key Players of Tablets
Table 7. Key Players of Solution
Table 8. Key Players of Syrups
Table 9. Key Players of Pills
Table 10. Key Players of Injection
Table 11. Key Players of Other
Table 12. Global Cold Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Cold Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Cold Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Cold Medicine Market Share by Region (2017-2022)
Table 16. Global Cold Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Cold Medicine Market Share by Region (2023-2028)
Table 18. Cold Medicine Market Trends
Table 19. Cold Medicine Market Drivers
Table 20. Cold Medicine Market Challenges
Table 21. Cold Medicine Market Restraints
Table 22. Global Cold Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Cold Medicine Market Share by Players (2017-2022)
Table 24. Global Top Cold Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Medicine as of 2021)
Table 25. Ranking of Global Top Cold Medicine Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Cold Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Cold Medicine Product Solution and Service
Table 29. Date of Enter into Cold Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cold Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Cold Medicine Revenue Market Share by Type (2017-2022)
Table 33. Global Cold Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Cold Medicine Revenue Market Share by Type (2023-2028)
Table 35. Global Cold Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Cold Medicine Revenue Market Share by Application (2017-2022)
Table 37. Global Cold Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Cold Medicine Revenue Market Share by Application (2023-2028)
Table 39. North America Cold Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Cold Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Cold Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Cold Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia-Pacific Cold Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 44. Asia-Pacific Cold Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 45. Latin America Cold Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 46. Latin America Cold Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 47. Middle East & Africa Cold Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 48. Middle East & Africa Cold Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 49. Wyeth (Pfizer) Company Detail
Table 50. Wyeth (Pfizer) Business Overview
Table 51. Wyeth (Pfizer) Cold Medicine Product
Table 52. Wyeth (Pfizer) Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 53. Wyeth (Pfizer) Recent Development
Table 54. Atley Pharmaceuticals Company Detail
Table 55. Atley Pharmaceuticals Business Overview
Table 56. Atley Pharmaceuticals Cold Medicine Product
Table 57. Atley Pharmaceuticals Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 58. Atley Pharmaceuticals Recent Development
Table 59. Vertical Pharmaceuticals Company Detail
Table 60. Vertical Pharmaceuticals Business Overview
Table 61. Vertical Pharmaceuticals Cold Medicine Product
Table 62. Vertical Pharmaceuticals Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 63. Vertical Pharmaceuticals Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Cold Medicine Product
Table 67. Novartis Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Merck Company Detail
Table 70. Merck Business Overview
Table 71. Merck Cold Medicine Product
Table 72. Merck Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 73. Merck Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Cold Medicine Product
Table 77. Sanofi Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Johnson & Johnson Company Detail
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Cold Medicine Product
Table 82. Johnson & Johnson Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. Toray Industries Company Detail
Table 85. Toray Industries Business Overview
Table 86. Toray Industries Cold Medicine Product
Table 87. Toray Industries Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 88. Toray Industries Recent Development
Table 89. Bayer Company Detail
Table 90. Bayer Business Overview
Table 91. Bayer Cold Medicine Product
Table 92. Bayer Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Bristol-Myers Squibb Company Detail
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Cold Medicine Product
Table 97. Bristol-Myers Squibb Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Tongrentang Pharmaceutical Company Detail
Table 100. Tongrentang Pharmaceutical Business Overview
Table 101. Tongrentang Pharmaceutical Cold MedicineProduct
Table 102. Tongrentang Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 103. Tongrentang Pharmaceutical Recent Development
Table 104. Jinghua Pharmaceutical Group Company Detail
Table 105. Jinghua Pharmaceutical Group Business Overview
Table 106. Jinghua Pharmaceutical Group Cold MedicineProduct
Table 107. Jinghua Pharmaceutical Group Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 108. Jinghua Pharmaceutical Group Recent Development
Table 109. Jiangxi Heying Pharmaceutical Company Detail
Table 110. Jiangxi Heying Pharmaceutical Business Overview
Table 111. Jiangxi Heying Pharmaceutical Cold MedicineProduct
Table 112. Jiangxi Heying Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 113. Jiangxi Heying Pharmaceutical Recent Development
Table 114. Diao Group Chengdu Pharmaceutical Company Detail
Table 115. Diao Group Chengdu Pharmaceutical Business Overview
Table 116. Diao Group Chengdu Pharmaceutical Cold MedicineProduct
Table 117. Diao Group Chengdu Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 118. Diao Group Chengdu Pharmaceutical Recent Development
Table 119. Shanghai Shangyao Xinyi Pharmaceutical Company Detail
Table 120. Shanghai Shangyao Xinyi Pharmaceutical Business Overview
Table 121. Shanghai Shangyao Xinyi Pharmaceutical Cold MedicineProduct
Table 122. Shanghai Shangyao Xinyi Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 123. Shanghai Shangyao Xinyi Pharmaceutical Recent Development
Table 124. Harbin Children Pharmaceutical Company Detail
Table 125. Harbin Children Pharmaceutical Business Overview
Table 126. Harbin Children Pharmaceutical Cold MedicineProduct
Table 127. Harbin Children Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 128. Harbin Children Pharmaceutical Recent Development
Table 129. Huarun Sanjiu Pharmaceutical Company Detail
Table 130. Huarun Sanjiu Pharmaceutical Business Overview
Table 131. Huarun Sanjiu Pharmaceutical Cold MedicineProduct
Table 132. Huarun Sanjiu Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 133. Huarun Sanjiu Pharmaceutical Recent Development
Table 134. Xinjiang Quanan Pharmaceutical Company Detail
Table 135. Xinjiang Quanan Pharmaceutical Business Overview
Table 136. Xinjiang Quanan Pharmaceutical Cold MedicineProduct
Table 137. Xinjiang Quanan Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 138. Xinjiang Quanan Pharmaceutical Recent Development
Table 139. Jiangsu Huayang Pharmaceutical Company Detail
Table 140. Jiangsu Huayang Pharmaceutical Business Overview
Table 141. Jiangsu Huayang Pharmaceutical Cold MedicineProduct
Table 142. Jiangsu Huayang Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 143. Jiangsu Huayang Pharmaceutical Recent Development
Table 144. Nanjing Chenggong Pharmaceutical Company Detail
Table 145. Nanjing Chenggong Pharmaceutical Business Overview
Table 146. Nanjing Chenggong Pharmaceutical Cold MedicineProduct
Table 147. Nanjing Chenggong Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 148. Nanjing Chenggong Pharmaceutical Recent Development
Table 149. Beijing Jiulong Pharmaceutical Company Detail
Table 150. Beijing Jiulong Pharmaceutical Business Overview
Table 151. Beijing Jiulong Pharmaceutical Cold MedicineProduct
Table 152. Beijing Jiulong Pharmaceutical Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 153. Beijing Jiulong Pharmaceutical Recent Development
Table 154. Livzon Pharmaceutical Group Company Detail
Table 155. Livzon Pharmaceutical Group Business Overview
Table 156. Livzon Pharmaceutical Group Cold MedicineProduct
Table 157. Livzon Pharmaceutical Group Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 158. Livzon Pharmaceutical Group Recent Development
Table 159. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
Table 160. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 161. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Cold MedicineProduct
Table 162. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 163. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 164. Sinopharm Company Detail
Table 165. Sinopharm Business Overview
Table 166. Sinopharm Cold MedicineProduct
Table 167. Sinopharm Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 168. Sinopharm Recent Development
Table 169. CSPC Company Detail
Table 170. CSPC Business Overview
Table 171. CSPC Cold MedicineProduct
Table 172. CSPC Revenue in Cold Medicine Business (2017-2022) & (US$ Million)
Table 173. CSPC Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cold Medicine Market Share by Type: 2021 VS 2028
Figure 2. Drops Features
Figure 3. Dropping Pill Features
Figure 4. Capsule Features
Figure 5. Granules Features
Figure 6. Tablets Features
Figure 7. Solution Features
Figure 8. Syrups Features
Figure 9. Pills Features
Figure 10. Injection Features
Figure 11. Other Features
Figure 12. Global Cold Medicine Market Share by Application in 2021 & 2028
Figure 13. Baby Case Studies
Figure 14. Young Children Case Studies
Figure 15. Preschooler Case Studies
Figure 16. School-Age Children Case Studies
Figure 17. Adult Case Studies
Figure 18. Cold Medicine Report Years Considered
Figure 19. Global Cold Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 20. Global Cold Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Cold Medicine Market Share by Region: 2021 VS 2028
Figure 22. Global Cold Medicine Market Share by Players in 2021
Figure 23. Global Top Cold Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Medicine as of 2021)
Figure 24. The Top 10 and 5 Players Market Share by Cold Medicine Revenue in 2021
Figure 25. North America Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. North America Cold Medicine Market Share by Country (2017-2028)
Figure 27. United States Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Canada Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Europe Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Europe Cold Medicine Market Share by Country (2017-2028)
Figure 31. Germany Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Cold Medicine Market Share by Region (2017-2028)
Figure 39. China Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Cold Medicine Market Share by Country (2017-2028)
Figure 47. Mexico Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Cold Medicine Market Share by Country (2017-2028)
Figure 51. Turkey Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Cold Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Wyeth (Pfizer) Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 54. Atley Pharmaceuticals Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 55. Vertical Pharmaceuticals Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 59. Johnson & Johnson Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 60. Toray Industries Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 61. Bayer Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 63. Tongrentang Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 64. Jinghua Pharmaceutical Group Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 65. Jiangxi Heying Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 66. Diao Group Chengdu Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 67. Shanghai Shangyao Xinyi Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 68. Harbin Children Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 69. Huarun Sanjiu Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 70. Xinjiang Quanan Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 71. Jiangsu Huayang Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 72. Nanjing Chenggong Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 73. Beijing Jiulong Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 74. Livzon Pharmaceutical Group Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 75. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 76. Sinopharm Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 77. CSPC Revenue Growth Rate in Cold Medicine Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs